BNOVATE TECHNOLOGIES SA

Their core work

BNovate Technologies is a Swiss water-technology SME developing automated, real-time microbial monitoring instruments for drinking water safety. Their core product, ColiSense Online, enables continuous E. coli detection directly in water distribution networks — replacing slow, lab-based sampling with instant, inline measurement. The company followed the classic SME Instrument commercialization path: a Phase 1 feasibility study in 2018 followed by a full Phase 2 development and market-entry project (€1.69M) from 2019 to 2021. Based near EPFL in Ecublens, they operate at the intersection of analytical chemistry, microbiology, and industrial sensing.

What they specialise in

How they've shifted over time

BNovate's H2020 track record covers only 2019–2021 and both projects are the same product at successive development stages, so there is no meaningful thematic shift to observe. What the timeline does reveal is a focused, linear commercialization trajectory: from a short feasibility check (2018, €50k) to a full-scale product development and market-entry project (2019–2021, €1.69M). This is the behavior of a company with a single, well-defined technology bet rather than a research portfolio that pivots over time.

BNovate completed their EIC SME Instrument journey in 2021 and is likely post-funding, in active market deployment — a potential partner for pilots in water utilities or industrial water treatment rather than new R&D consortia.

How they like to work

BNovate operated exclusively as sole coordinator on both projects, with no recorded consortium partners — this is the standard mode for SME Instrument grants, which are designed for single companies commercializing their own technology. They have not participated as a consortium partner in any H2020 project, meaning they have no track record of collaborative research with other institutions. A future partner should expect to work with them as a technology provider or pilot-site supplier, not as a co-researcher in a multi-partner consortium.

BNovate has no recorded consortium partners across their two H2020 projects, both of which were solo SME Instrument grants. Their H2020 network is effectively a single node — the company itself — with no cross-border research collaboration on record.

What sets them apart

BNovate occupies a narrow but commercially valuable niche: real-time, automated E. coli detection at the point of supply, which addresses a genuine gap in water safety monitoring where lab turnaround times are too slow for operational decisions. Their Swiss location near EPFL, combined with successful EIC Phase 2 funding, suggests credible technical depth and some level of institutional validation. For a consortium needing a sensor or instrument provider in water quality applications, they offer a finished (or near-finished) product rather than research-stage technology.

Highlights from their portfolio

• ColiSense Online (Phase 2)
  The largest of their two grants at €1.69M, this EIC SME Instrument Phase 2 project represents a full commercial development push — the kind of outcome-oriented grant awarded only after a validated business case, making it strong evidence of product maturity.
• ColiSense Online (Phase 1)
  The Phase 1 feasibility award in 2018 is notable as the starting point of a successful two-phase EIC journey, confirming the idea survived competitive EU evaluation before the larger investment was made.